pbpk modeling and simulation for regulatory decision making: impact on us prescribing information
Published 2 years ago • 547 plays • Length 50:49Download video MP4
Download video MP3
Similar videos
-
1:02:16
leveraging dermal pbpk modeling and simulation approaches
-
49:40
pbpk modeling and simulation: bridging the “bottom up” and “top-down” approaches
-
40:57
precision dosing using pbpk modeling
-
3:39
common myths about pbpk modeling and simulation- busted!
-
59:17
applications of pbpk modelling for regulatory submissions: case studies
-
55:39
a best practice framework for applying pbpk modeling to pediatric drug development
-
54:19
de-risk pre-ind stage decisions with simcyp discovery pbpk software
-
1:01:14
pbpk modeling & simulation to support asciminib nda submission and inform drug product label
-
59:49
pbpk modeling approaches to assess risks associated with bioequivalence in drug development
-
1:52
pbpk modeling supports approval of breakthrough cancer drug
-
13:20
developing compound files for pbpk modeling in the simcyp simulator
-
0:36
certara | 4a decision framework
-
59:23
first-in-human (fih) faster: the power of physiologically based pharmacokinetic (pbpk) modeling
-
14:14
certara's simcyp simulator demo
-
3:39
didb introduction
-
20:08
1 introduction to pbpk modeling
-
1:02:46
solving a mystery using pbpk: how drug-excipient complexes can confound a metabolic ddi result